Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
3.16
- 0.03 (-0.94%)
4:00 PM ET on Sep 26, 2016
Delayed at least 20 minutes.
Day High 3.20
Day Low 3.12
52-Week High 7.46
Volume 225,182
Print Friendly